Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICCOLO Trial
2005-003492-20Phase 3Completed
- Sponsor
- University of Leeds
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of irinotecan in colorectal adenocarcinoma (3 arms), sponsored by University of Leeds. Primary endpoints: Toxicity of irinotecan therapy with ciclosporin modulation and Efficacy of irinotecan plus panitumumab in KRAS wild-type tumors. Started Mar 2006; status: completed.
02
Drugs
irinotecan
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on 2005-003492-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003492-20.